Cerus Corp.

NASDAQ:CERS  
5.94
+0.15 (+2.59%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.04B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$31.4 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$5.70
50-Day MA$5.89
200-Day MA$6.42
See more pivots

Cerus Corp. Stock, NASDAQ:CERS

1220 Concord Avenue, Suite 600, Concord, California 94520
United States of America
Phone: +1.925.288.6000
Number of Employees: 270

Description

Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. The firm produces blood system for platelets and plasma. It operates through Blood Safety segment. It markets products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.